REDHILL BIOPHARMA LTD. Weighted Average Fair Value At Measurement Date Share Options Granted
REDHILL BIOPHARMA LTD. (RDHL) had Weighted Average Fair Value At Measurement Date Share Options Granted of $5.23 million as of 2020-12-31, per its 20-F filed 2022-03-17.
Discontinued › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2022-03-17
- 2020-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $5.23M.
- 2020-06-30: Weighted Average Fair Value At Measurement Date Share Options Granted $4.83M.
- 2019-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $4.67M.
- 2019-06-30: Weighted Average Fair Value At Measurement Date Share Options Granted $3.70M.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted |
|---|---|
| 2020-12-31 | $5.23M 20-F · filed 2022-03-17 |
| 2020-06-30 | $4.83M 6-K · filed 2020-08-13 |
| 2019-12-31 | $4.67M 20-F · filed 2021-03-18 |
| 2019-06-30 | $3.70M 6-K · filed 2019-07-23 |
| 2018-12-31 | $1.69M 20-F · filed 2020-03-04 |
| 2017-12-31 | $3.50M 20-F · filed 2019-02-26 |
| 2016-12-31 | $1.23M 20-F · filed 2018-02-22 |